Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 08/06/20061 min de lecture
Oral Dosage Form New Animal Drugs; Oxibendazole Suspension
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for revised food safety labeling for oxibendazole suspension administered orally to horses as an antiparasitic.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →